173 related articles for article (PubMed ID: 26332649)
1. Pictorial representation of illness and self measure (PRISM): an effective tool to assess the burden of psoriasis.
Fotiou K; Hofmann M; Kaufmann R; Thaci D
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2356-62. PubMed ID: 26332649
[TBL] [Abstract][Full Text] [Related]
2. Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients.
Mühleisen B; Büchi S; Schmidhauser S; Jenewein J; French LE; Hofbauer GF
Arch Dermatol; 2009 Jul; 145(7):774-80. PubMed ID: 19620558
[TBL] [Abstract][Full Text] [Related]
3. Validation of PRISM (Pictorial Representation of Illness and Self Measure) as a novel visual assessment tool for the burden of suffering in tinnitus patients.
Peter N; Kleinjung T; Horat L; Schmidt-Weitmann S; Meyer M; Büchi S; Weidt S
Health Qual Life Outcomes; 2016 Mar; 14():47. PubMed ID: 27001548
[TBL] [Abstract][Full Text] [Related]
4. Validating PRISM (Pictorial Representation of Illness and Self Measure) as a measure of suffering in chronic non-cancer pain patients.
Kassardjian CD; Gardner-Nix J; Dupak K; Barbati J; Lam-McCullock J
J Pain; 2008 Dec; 9(12):1135-43. PubMed ID: 18755635
[TBL] [Abstract][Full Text] [Related]
5. Pictorial Representation of Illness and Self-Measure to assess the perceived burden in patients with chronic inflammatory vulvar diseases: an observational study.
Corazza M; Virgili A; Toni G; Valpiani G; Morotti C; Borghi A
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2645-2651. PubMed ID: 32597539
[TBL] [Abstract][Full Text] [Related]
6. Suffering quantified? Feasibility and psychometric characteristics of 2 revised versions of the Pictorial Representation of Illness and Self Measure (PRISM).
Wouters EJ; Reimus JL; van Nunen AM; Blokhorst MG; Vingerhoets AJ
Behav Med; 2008; 34(2):65-78. PubMed ID: 18682339
[TBL] [Abstract][Full Text] [Related]
7. The Pictorial Representation of Illness and Self Measure (PRISM) instrument reveals a high burden of suffering in patients with chronic urticaria.
Töndury B; Muehleisen B; Ballmer-Weber BK; Hofbauer G; Schmid-Grendelmeier P; French L; Büchi S
J Investig Allergol Clin Immunol; 2011; 21(2):93-100. PubMed ID: 21462798
[TBL] [Abstract][Full Text] [Related]
8. The relationship between quality of life and the severity of psoriasis in Turkey.
Çakmur H; Derviş E
Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
[TBL] [Abstract][Full Text] [Related]
9. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
[TBL] [Abstract][Full Text] [Related]
10. Suffering in psoriasis patients: its relation with illness severity and subjective well-being.
Reimus JL; Vingerhoets AJ; Soons PH; Korstanje MJ
Int J Dermatol; 2007 Oct; 46(10):1042-5. PubMed ID: 17910711
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
Tang MM; Chang CC; Chan LC; Heng A
Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
[TBL] [Abstract][Full Text] [Related]
12. Preliminary validation of PRISM (Pictorial Representation of Illness and Self Measure) - a brief method to assess suffering.
Büchi S; Buddeberg C; Klaghofer R; Russi EW; Brändli O; Schlösser C; Stoll T; Villiger PM; Sensky T
Psychother Psychosom; 2002; 71(6):333-41. PubMed ID: 12411768
[TBL] [Abstract][Full Text] [Related]
13. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis.
Balato N; Megna M; Di Costanzo L; Balato A; Ayala F
Br J Dermatol; 2013 Jan; 168(1):201-5. PubMed ID: 23240729
[TBL] [Abstract][Full Text] [Related]
14. Pictorial Representation of Illness and Self Measure Revised II (PRISM-RII): a novel method to assess perceived burden of illness in diabetes patients.
Klis S; Vingerhoets AJ; de Wit M; Zandbelt N; Snoek FJ
Health Qual Life Outcomes; 2008 Nov; 6():104. PubMed ID: 19038050
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 2 of 2): use of quality of life to assess construct validity of the Lattice System Physician's Global Assessment, Psoriasis Area and Severity Index and Static Physician's Global Assessment.
Simpson MJ; Chow C; Morgenstern H; Luger TA; Ellis CN
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1415-20. PubMed ID: 25917214
[TBL] [Abstract][Full Text] [Related]
16. A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.
Berth-Jones J; Grotzinger K; Rainville C; Pham B; Huang J; Daly S; Herdman M; Firth P; Hotchkiss K
Br J Dermatol; 2006 Oct; 155(4):707-13. PubMed ID: 16965419
[TBL] [Abstract][Full Text] [Related]
17. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.
Bożek A; Reich A
Adv Clin Exp Med; 2017 Aug; 26(5):851-856. PubMed ID: 29068583
[TBL] [Abstract][Full Text] [Related]
18. Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials.
Shikiar R; Bresnahan BW; Stone SP; Thompson C; Koo J; Revicki DA
Health Qual Life Outcomes; 2003 Oct; 1():53. PubMed ID: 14613569
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
20. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature.
Puzenat E; Bronsard V; Prey S; Gourraud PA; Aractingi S; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Paul C; Richard-Lallemand MA; Ortonne JP; Aubin F
J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():10-6. PubMed ID: 20443995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
